ArticleWorld journal of surgical oncology2026
Machine learning for predicting high axillary nodal burden in breast cancer patients with positive sentinel lymph nodes.
Article in World journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundTo develop and validate a machine learning-based predictive model for identifying high axillary nodal burden (≥ pN2) in SLNB-positive breast cancer patients, integrating preoperative, intraoperative, and pathological features to support clinical decision-making when ALND is omitted.
methodsA retrospective study was conducted at a single institution between 2020 and 2024, enrolling 956 breast cancer patients who underwent both SLNB and ALND. Clinicopathological variables (preoperative imaging, intraoperative SLN findings, postoperative pathology) were collected. The cohort was randomly split into a training set (70%, n = 670) and a validation set (30%, n = 286). Features were selected via univariate analysis (p < 0.05), LASSO regression (λ1se criterion), and the Boruta algorithm. Nine machine learning models were trained and evaluated using AUC, accuracy, sensitivity, specificity, and F1-score. SHAP analysis was used to interpret the optimal model, and a clinical nomogram was developed based on logistic regression.
resultsThe prevalence of high nodal burden (≥ pN2) was 15.3% (146/956). Seven key predictors were identified: Neurological invasion、Lymph vascular invasion、Imaging abnormal nodes、Lymph nodes size、Tumor size、Negative SLN、Positive SLN. Logistic Regression (validation AUC: 0.850, accuracy: 0.857, F1-score: 0.602) and Support Vector Machine (validation AUC: 0.857, accuracy: 0.853, F1-score: 0.596) demonstrated the most stable performance across datasets. A nomogram was developed for intuitive clinical use.
conclusionThe proposed machine learning model accurately predicts high nodal burden in SLNB-positive breast cancer patients, facilitating individualized adjuvant therapy planning and avoiding unnecessary ALND.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.